A protease-based strategy for the controlled release of therapeutic peptides

Angewandte Chemie - International Edition

Volumn 49, Issue 29, 2010, Pages 4930-4933

  Li, Hongjian ^a   Ma, Yi ^a   Chen, Ying ^a   Sang, Yanxia ^a   Zhou, Tianhong ^a   Qiu, Meilan ^a   Huang, Xiumei ^a   Zhou, Cindy ^b,c   Su, Zhengding ^b,c  

^a JINAN UNIVERSITY   (China)

^b UNIVERSITY OF WATERLOO   (Canada)

^c Amersino Biodevelop Inc   (Canada)

Author keywords

Antidiabetic agents; Controlled release; Drug delivery; Peptides; Proteases

Indexed keywords

AMINO ACID SEQUENCE; ANTIDIABETIC AGENTS; CONTROLLED RELEASE; CONTROLLED RELEASE DRUGS; HUMAN SERUM ALBUMINS; THERAPEUTIC PEPTIDES;

AMINO ACIDS; ORGANIC ACIDS; PEPTIDES;

CONTROLLED DRUG DELIVERY;

ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1; PEPTIDE; PEPTIDE HYDROLASE; SERUM ALBUMIN; THROMBIN; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; HALF LIFE TIME; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; GLUCAGON-LIKE PEPTIDE 1; HALF-LIFE; HUMANS; HYPOGLYCEMIC AGENTS; PEPTIDE HYDROLASES; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN; THROMBIN;

EID: 77954327237     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201000287     Document Type: Article

References (27)

1. V. Marx, Chem Eng. News 2005, 83, 17-24.
2. A. K. Pavlou, J. M. Reichert, Nat. Biotechnol. 2004, 22, 1513-1519.
3. A. K. Sato, M. Viswanathan, R. B. Kent, C. R. Wood, Curr. Opin. Biotechnol. 2006, 17, 638-642.
4. S. Lien, H. B. Lowman, Trends Biotechnol. 2003, 21, 556-562.
5. D. P. McGregor, Curr. Opin. Pharmacol. 2008, 8, 616-619.
6. D. Kumar Malik, S. Baboota, A. Ahuja, S. Hasan, J. Ali, Curr. Drug Delivery 2007, 4, 141-151.
7. R. Pawar, A. Ben Ari, A. J. Domb, Expert Opin. Biol. Ther. 2004, 4, 1203-1212.
8. L. L. Baggio, Q. Huang, T. J. Brown, D. J. Drucker, Diabetes 2004, 55, 2492-2500.
9. M. S. Dennis, M. Zhang, Y. G. Meng, M. Kadkhodayan, D. Kirchhofer, D. Combs, L. A. Damico, J. Biol. Chem. 2002, 277, 35035-35043.
10. P. Holliger, P. J. Hudson, Nat. Biotechnol. 2005, 23, 1126-1136.
11. D. Muller, A. Karle, B. Meissburger, I. Hofig, R. Stork, R. E. Kontermann, J. Biol. Chem. 2007, 252, 12650-12660.
12. K. M. Picha, M. R. Cunningham, D. J. Drucker, A. Mathur, T. Ort, M. Scully, A. Soderman, T. Spinka-Doms, V. StojanovicSusulic, B. A. Thomas, K. T. O'Neil, Diabetes 2008, 57, 1926-1934.
13. Y. Shechter, M. Mironchik, S. Rubinraut, A. Saul, H. Tsubery, M. Fridkin, Bioconjugate Chem. 2005, 16, 913-920.
14. R. Stork, D. Muller, R. E. Kontermann, Protein Eng. Des. Sci. 2007, 20, 569-576.
15. T. R. McCurdy, S. Gataiance, L. J. Eltringham-Smith, W. P. Sheffield, J. Lab. Clin. Med. 2004, 143, 115-124.
16. M. C. Guillin, A. Bezeaud, M. C. Bouton, M. Jandrot-Perrus, Thromb. Haemostasis 1995, 74, 129-133.
17. L. G. Licari, J. P. Kovacic, J. Vet. Emerg. Crit. Care (San Antonio) 2009, 19, 11-22.
18. K. Borensztajn, M. P. Peppelenbosch, C. A. Spek, Trends Mol. Med. 2008, 14, 429-440.
19. I. Aoki, K. Shimoyama, N. Aoki, M. Homori, A. Yanagisawa, K. Nakahara, Y. Kawai, S. I. Kitamura, K. Ishikawa, J. Am. Coli. Cardiol. 1996, 27, 560-566.
20. Z. Cohen, R. F. Gonzales, G. F. Davis-Gorman, J. G. Copeland, P. F. McDonagh, Thromb. Res 2002, 107, 217-221.
21. S. Ludwig, S. Dharmalingam, S. Erickson-Nesmith, S. Ren, F. Zhu, G. M. Ma, R. Zhao, J. W. Fenton II, F. A. Ofosu, H. te Velthuis, Q van Mierlo, Q X. Shen, Diabetes Res. Clin. Pract. 2005, 70, 110-118.
22. Z. Su, A. Vinogradova, A. Koutychenko, D. Tolkatchev, F. Ni, Protein Eng. Des. Sel. 2004, 17, 647-657.
23. A. Barnett, Expert Opin. Pharmacother. 2007, 8, 2593-2608.
24. D. A. D'Alessio, T. P. Vahl, Am. J. Physiol. Endocrinol. Metab. 2004, 286, E882-E890.
25. J. F. Todd, S. R. Bloom, Diabetic Med. 2007, 24, 223-232.
26. A. H. Stonehouse, J. H. Holcombe, D. M. Kendall, Expert Opin. Pharmacother. 2006, 7, 2095-2105.
27. D. Elahi, J. M. Egan, R. P. Shannon, G. S. Meneilly, A. Khatri, J. F. Habener, D. K. Andersen, Obesity 2008, 16, 1501-1509.